The Neurological Impact of the Green Tea (Camellia sinensis) Catechin EGCG on Parkinson’s Disease
DOI:
https://doi.org/10.47611/jsrhs.v13i3.7412Keywords:
Camellia sinensis, Parkinson's disease, neurology, in vitro, in vivo, neuronal degenerationAbstract
Parkinson’s disease (PD) is a slow-onset neurodegenerative disease, the second most prevalent, after Alzheimer’s disease. In all neurodegenerative diseases, neuronal degeneration is inevitable and results in the depletion of function in several regions of the brain, causing the symptoms of such diseases. Though it is prevalent, Parkinson’s disease currently has no cure. Due to this lack of a cure, for decades, researchers have been either trying to find a cure for the life-changing disease, or they have been trying to discover approaches to mitigate the symptoms and side effects of PD. One such approach that has been looked into, is the consumption of green tea by patients battling PD. Green tea, scientifically known as Camellia sinensis, contains several catechins, a type of polyphenol (naturally found compounds in many beverages), which demonstrate several beneficial properties, many being neuroprotective. The most prominent catechin found in green tea is epigallocatechin-3-gallate (EGCG), known for its health benefits. This article aims to explore and analyze studies done regarding general green tea components and EGCG, including its neuroprotective implications on Parkinson’s disease. Both in vitro and in vivo studies have been done to examine the overall benefits of green tea on PD. Such benefits include a reduction in symptoms of PD, reduced risk of PD development, and overall protection against neuronal damage: factors that this study aims to explore.
Downloads
References or Bibliography
OHDA Parkinson Model, Animal Model Of Parkinson’s | Melior. (n.d.). Melior Discovery. https://www.meliordiscovery.com/in-vivo-efficacy-models/6-ohda-lesion-in-rat/
Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., & Wanker, E. E. (2010). EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proceedings of the National Academy of Sciences, 107(17), 7710–7715. https://doi.org/10.1073/pnas.0910723107
Brownstein, A. (2024, January 4). EGCG: A Green Tea Antioxidant With Health Benefits. Verywell Health. https://www.verywellhealth.com/egcg-supplement-benefits-and-safety-8404078
Chan, D. K., Woo, J., Ho, S. C., Pang, C. P., Law, L. K., Ng, P. W., Hung, W. T., Kwok, T., Hui, E., Orr, K., Leung, M. F., & Kay, R. (1998). Genetic and environmental risk factors for Parkinson’s disease in a Chinese population. Journal of Neurology, Neurosurgery, and Psychiatry, 65(5), 781–784. https://doi.org/10.1136/jnnp.65.5.781
Cleveland Clinic. (2020). Parkinson’s disease: Causes, Symptoms, Stages, Treatment, Support. Cleveland Clinic; Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/8525-parkinsons-disease-an-overview
Korgiopoulou, C. (2020, July 29). EGCG Alpha Synuclein Oligomers | StressMarq. StressMarq Biosciences Inc. https://www.stressmarq.com/egcg-alpha-synuclein-oligomers/
Levites, Y., Weinreb, O., Maor, G., Youdim, M. B. H., & Mandel, S. (2001). Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. Journal of Neurochemistry, 78(5), 1073–1082. https://doi.org/10.1046/j.1471-4159.2001.00490.x
Malar, D. S., Prasanth, M. I., Brimson, J. M., Sharika, R., Sivamaruthi, B. S., Chaiyasut, C., & Tencomnao, T. (2020). Neuroprotective Properties of Green Tea (Camellia sinensis) in Parkinson’s Disease: A Review. Molecules, 25(17). https://doi.org/10.3390/molecules25173926
Mandel, S. A., Amit, T., Weinreb, O., Reznichenko, L., & Youdim, M. B. H. (2008). Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neuroscience & Therapeutics, 14(4), 352–365. https://doi.org/10.1111/j.1755-5949.2008.00060.x
Marras, C., Beck, J. C., Bower, J. H., Roberts, E., Ritz, B., Ross, G. W., Abbott, R. D., Savica, R., Van Den Eeden, S. K., Willis, A. W., & Tanner, C. (2018). Prevalence of Parkinson’s disease across North America. Npj Parkinson’s Disease, 4(1). https://doi.org/10.1038/s41531-018-0058-0
Meade, R. M., Fairlie, D. P., & Mason, J. M. (2019). Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles. Molecular Neurodegeneration, 14(1). https://doi.org/10.1186/s13024-019-0329-1
Natália Bitu Pinto, Bruno, Rose, K., Aline Holanda Silva, Almeida, K., & Viana, B. (2015). Neuroprotective Properties of the Standardized Extract fromCamellia sinensis(Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson’s Disease. Evidence-Based Complementary and Alternative Medicine, 2015, 1–12. https://doi.org/10.1155/2015/161092
Parkinson’s and alpha-synuclein. (n.d.). Cure Parkinson’s. https://cureparkinsons.org.uk/parkinsons-and-alpha-synuclein/
Pervin, M., Unno, K., Ohishi, T., Tanabe, H., Miyoshi, N., & Nakamura, Y. (2018). Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases. Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry, 23(6). https://doi.org/10.3390/molecules23061297
Prasanth, M., Sivamaruthi, B., Chaiyasut, C., & Tencomnao, T. (2019). A Review of the Role of Green Tea (Camellia sinensis) in Antiphotoaging, Stress Resistance, Neuroprotection, and Autophagy. Nutrients, 11(2), 474. https://doi.org/10.3390/nu11020474
Simon. (2016, November 29). Get more EGCG. Drink green tea. The Science of Parkinson’s. https://scienceofparkinsons.com/2016/11/29/get-more-egcg-drink-green-tea/
Simon. (2018, September 15). EGCG: Anyone fancy a cuppa? The Science of Parkinson’s. https://scienceofparkinsons.com/2018/09/15/egcg/
Yao, Y., Tang, Y., & Wei, G. (2020). Epigallocatechin Gallate Destabilizes α-Synuclein Fibril by Disrupting the E46-K80 Salt-Bridge and Inter-protofibril Interface. ACS Chemical Neuroscience, 11(24), 4351–4361. https://doi.org/10.1021/acschemneuro.0c00598
Zhen, C., Li, D., Wang, H., Wang, P., Zhang, W., Yu, J., Yu, X., & Wang, X. (2019, March 1). Tea consumption and risk of Parkinson’s disease: A meta-analysis. | Neurology Asia | EBSCOhost. Openurl.ebsco.com. https://openurl.ebsco.com/EPDB%3Agcd%3A7%3A3830439/detailv2?sid=ebsco%3Aplink%3Ascholar&id=ebsco%3Agcd%3A135723165&crl=c
Zhou, T., Zhu, M., & Liang, Z. (2018). (-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson’s disease. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2018.8470
Published
How to Cite
Issue
Section
Copyright (c) 2024 Meghna Kapa; Dr. Jobin Varkey, Professor Virgel Torremocha, Jothsna Kethar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
